U.S. drugmakers and biotechs have come to rely on Chinese partners. Now, some of them are looking for alternatives as geopolitical tensions rise.
Related Posts
Basic Materials Roundup: Market Talk
Find insight on Glencore, Impala Platinum and more in the latest Market Talks covering Basic Materials.
Microsoft Faces U.K. Antitrust Probe Over Ties to Inflection AI
U.K. investigation is the latest into the tech company’s ties with artificial-intelligence startups.
Mexican Food Chain Guzman Y Gomez Soars After Australia’s Biggest IPO of 2024
The Mexican food chain which wants to operate as many restaurants in Australia as McDonald’s, began trading on Australia’s stock exchange after the biggest initial […]